All India Drug Action Network (AIDAN)

The homepage of All India Drug Action Network

Skip to content

Home
Membership
About us
Rational & Essential Drugs
Clinical Trials
Drug Pricing
Drug Promotion
Pharma Policy
IPR Issues
Polio
Resources
Contact

Drug Promotion

Marketing of drugs

Drug Promotion, Clinical Trials and Conflicts

Like this:

Like Loading...

Leave a Reply Cancel reply

Enter your comment here...

Fill in your details below or click an icon to log in:

Email (required) (Address never made public)

Name (required)

Website

You are commenting using your WordPress.com account. ( Log Out / Change )

You are commenting using your Twitter account. ( Log Out / Change )

You are commenting using your Facebook account. ( Log Out / Change )

Connecting to %s

Notify me of follow-up comments via email.

Search for:

Recent Posts

The EU says no to ACTA: to protect public health, other countries should also reject it
Compulsory Licensing in India: A historic move to make drugs affordable
Open letter to DG, WHO – Pentavalent vaccine related deaths in India
Global Week of Action: India- EU Free Trade Agreement (FTA)
A victory for Novartis could spell death for millions

Tags
ACTA AIDAN Annual Meet Book release Clinical Trials Conflict of Interest draft policy Drug Pricing Drug Promotion Essential Drugs essential medicines EU Generic drug Global Health Health India India-EU FTA IPR Letter Marketing Medical Council of India Medicine Medicine pricing Medicines National Pharmaceuticals Pricing Policy Patent Pharma Industry Pharma Policy Photo PIL Polio Price Control Rational Drugs Sec 3 (d) Supreme Court of India TRIPS Vaccine WHO WTO
Blog Stats
- 42,070 hits
Email Subscription

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 69 other followers

Theme: Coraline by Automattic. Blog at WordPress.com.

Follow

Follow “All India Drug Action Network (AIDAN)”

Get every new post delivered to your Inbox.

Join 69 other followers

Powered by WordPress.com

%d bloggers like this: